Recombinant FVIII product type and the risk of inhibitor development in previously treated patients with hemophilia A: a systematic review and meta-analysis

被引：0
|
作者：
Hassan, S. [1 ]
Cannavo, A. [2 ,3 ]
van der Bom, J. [1 ]
Gouw, S. [1 ]
Rosendaal, F. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Clin Epidemiol, Leiden, Netherlands
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[3] Luigi Villa Fdn, Milan, Italy
来源：
HAEMOPHILIA | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P191
引用
下载
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression
    Xi, M.
    Makris, M.
    Marcucci, M.
    Santagostino, E.
    Mannucci, P. M.
    Iorio, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) : 1655 - 1662
  • [2] The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
    Kim, Ju Young
    You, Chur Woo
    BLOOD RESEARCH, 2019, 54 (03) : 204 - 209
  • [3] Risk factors for inhibitor development in patients with hemophilia A: the role of factor VIII (FVIII) product type
    Mancuso, M. E.
    Mannucci, P. M.
    Rocino, A.
    Garagiola, I
    Tagliaferri, A.
    Di Perna, C.
    Santagostino, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 685 - 685
  • [4] Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a Treated with Nuwiq®, a New Generation Recombinant FVIII of Human Origin
    Liesner, Raina
    Abashidze, Marina
    Aleinikova, Olga
    Altisent, Carmen
    Belletrutti, Mark J.
    Borel-Derlon, Annie
    Carcao, Manuel
    Chambost, Herve
    Chan, Anthony
    Dubey, Leonid
    Ducore, Jonathan M.
    Abubacker, Fouzia Nambiathayil
    Gattens, Michael
    Gruel, Yves
    Kavardakova, Natalya
    Khorassani, Mohamed
    Klukowska, Anna
    Konigs, Christoph
    Lambert, Thierry
    Lohade, Sunil
    Sigaud, Marianne
    Turea, Valentin
    Wu, John K.
    Vdovin, Vladimir
    BLOOD, 2016, 128 (22)
  • [5] Systematic Review of the Role of FVIII Concentrates in Inhibitor Development in Previously Untreated Patients with Severe Hemophilia A: A 2013 Update
    Franchini, Massimo
    Coppola, Antonio
    Rocino, Angiola
    Santagostino, Elena
    Tagliaferri, Annarita
    Zanon, Ezio
    Morfini, Massimo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (07): : 752 - 766
  • [6] Inhibitor development as switching full-length recombinant FVIII to B-domain deleted recombinant FVIII in previously treated patients with hemophilia A: Taiwan's experience
    Chang, C-Y
    Chen, S-H
    Yeh, G-C
    Tsai, C-H
    Tsai, J-R
    Liu, Y-L
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 856 - 857
  • [7] The Impact of Recombinant Versus Plasma-Derived Factor VIII Concentrates on Inhibitor Development in Previously Untreated Patients With Hemophilia A: A 2021 Update of a Systematic Review and Meta-Analysis
    Kohar, Kelvin
    Prayogo, Stephanie A.
    Wiyono, Lowilius
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [8] F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
    Gouw, Samantha C.
    van den Berg, H. Marijke
    Oldenburg, Johannes
    Astermark, Jan
    de Groot, Philip G.
    Margaglione, Maurizio
    Thompson, Arthur R.
    van Heerde, Waander
    Boekhorst, Jorien
    Miller, Connie H.
    le Cessie, Saskia
    van der Bom, Johanna G.
    BLOOD, 2012, 119 (12) : 2922 - 2934
  • [9] Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis
    Bezzio, Cristina
    Vernero, Marta
    Ribaldone, Davide Giuseppe
    Alimenti, Eleonora
    Manes, Gianpiero
    Saibeni, Simone
    CANCERS, 2023, 15 (08)
  • [10] Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review
    Iorio, A.
    Halimeh, S.
    Holzhauer, S.
    Goldenberg, N.
    Marchesini, E.
    Marcucci, M.
    Young, G.
    Bidlingmaier, C.
    Brandao, L. R.
    Ettingshausen, C. E.
    Gringeri, A.
    Kenet, G.
    Knoefler, R.
    Kreuz, W.
    Kurnik, K.
    Manner, D.
    Santagostino, E.
    Mannucci, P. M.
    Nowak-Goettl, U.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) : 1256 - 1265
12345